DNA damage response (Homo sapiens)

From WikiPathways

Revision as of 07:48, 13 September 2010 by Stan.gaj (Talk | contribs)
Jump to: navigation, search
143-5, 9, 11...102, 3, 7, 15, 161, 13101410813-5, 9, 11...1686103-5, 9, 11...1083-5, 9, 11...101061, 13101, 1310143-5, 9, 11...101, 133-5, 9, 11...3-5, 9, 11...101610101, 1313Gene productActivationDNA repairSenescenceApoptosisROSCell-cycle progressionmitoch-ondrionDouble-strand breaksCell-cycleSpecialized:Somatic hypermutaionV(D)J recombinationClass switchingG2/M transitionROSBlocked replicationCellG1/S transitionCaption:DNA adductDNA repair and damage preventionChange in the Cell conditionDifferent pathwayChromatinremodellingCell survivalChromatin alterationReplication stressMetaboliteAlkylating agentsG2–MCheckpointExtral cellularSpaceExogenous:Cigarette SmokeCaffeineRadiation (UV)ClastogenesHypoxiaGenotoxic drugsBlocked transcriptionEndogenous:Collapsed replication forksSingle stranded DNA replication breaksFree radicals (ROS)DNA damage sourceG2/M checkpointInhibitionBulky DNA lesionDNA damage ATM dependentMembraneCASP9PIDDCCNB1CHEK1RRM2BE2F1CDK4BBC3RAD17GADD45GGADD45ABRCA1CCND2CASP8SMC1ACDC25CBAXRAD52CDK2TLK1CCNB3MDM2CDKN1BCaffeineFASRPA2CDK5ATMCHEK2PRKDCGADD45BATRIPSESN1RB17-hydroxystaurosporineCDKN1ACCNE1APAF1CYCSGADD45ACCNE2DDB2TLK2RAD50H2AFXc-MycCCND1PMAIP1TP53AIP1CCNB2RAD51TNFRSF10BBIDFANCD2MRE11CDK6ATREstradiolCREBRAD1PMLCDC2CDC25ASFNE2F1GADD45BNBNRAD9AHUS1GADD45GCCND3RB1TP53RFCCASP3ABL1


Description

This is the first pathway out of two pathways which deals with DNA damage response. It has two central gene products (ATM and ATR) which are connected to the sources of DNA damage (in blue). The two central genes can be divides furthermore into their most important genes. In the ATM pathway are the most important genes TP53 and CHEK2 and on the other hand in the ATR pathway is this CHEK1.

If it is not mentioned different, the processes take place in the cell cytoplasm.

The goal of this first pathway is to give an overview of the most important gene products, processes and changes in the cell condition through the DNA damage response pathway and at the same time to keep it clearly arranged

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Vousden KH, Lane DP; ''p53 in health and disease.''; Nat Rev Mol Cell Biol, 2007 PubMed Europe PMC Scholia
  2. Wang W; ''Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.''; Nat Rev Genet, 2007 PubMed Europe PMC Scholia
  3. Cory S, Huang DC, Adams JM; ''The Bcl-2 family: roles in cell survival and oncogenesis.''; Oncogene, 2003 PubMed Europe PMC Scholia
  4. Boutros R, Lobjois V, Ducommun B; ''CDC25 phosphatases in cancer cells: key players? Good targets?''; Nat Rev Cancer, 2007 PubMed Europe PMC Scholia
  5. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U; ''Dynamics of the p53-Mdm2 feedback loop in individual cells.''; Nat Genet, 2004 PubMed Europe PMC Scholia
  6. Chargari C, Toillon RA, Macdermed D, Castadot P, Magné N; ''Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?''; Lancet Oncol, 2009 PubMed Europe PMC Scholia
  7. Sherr CJ, Roberts JM; ''Living with or without cyclins and cyclin-dependent kinases.''; Genes Dev, 2004 PubMed Europe PMC Scholia
  8. Reshmi SC, Gollin SM; ''Chromosomal instability in oral cancer cells.''; J Dent Res, 2005 PubMed Europe PMC Scholia
  9. Gil J, Peters G; ''Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.''; Nat Rev Mol Cell Biol, 2006 PubMed Europe PMC Scholia
  10. Harrison JC, Haber JE; ''Surviving the breakup: the DNA damage checkpoint.''; Annu Rev Genet, 2006 PubMed Europe PMC Scholia
  11. Ljungman M, Lane DP; ''Transcription - guarding the genome by sensing DNA damage.''; Nat Rev Cancer, 2004 PubMed Europe PMC Scholia
  12. Zhou BB, Bartek J; ''Targeting the checkpoint kinases: chemosensitization versus chemoprotection.''; Nat Rev Cancer, 2004 PubMed Europe PMC Scholia
  13. Sengupta S, Harris CC; ''p53: traffic cop at the crossroads of DNA repair and recombination.''; Nat Rev Mol Cell Biol, 2005 PubMed Europe PMC Scholia
  14. Löbrich M, Jeggo PA; ''The impact of a negligent G2/M checkpoint on genomic instability and cancer induction.''; Nat Rev Cancer, 2007 PubMed Europe PMC Scholia
  15. Strasser A; ''The role of BH3-only proteins in the immune system.''; Nat Rev Immunol, 2005 PubMed Europe PMC Scholia
  16. Toledo F, Wahl GM; ''Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.''; Nat Rev Cancer, 2006 PubMed Europe PMC Scholia
  17. Sparmann A, van Lohuizen M; ''Polycomb silencers control cell fate, development and cancer.''; Nat Rev Cancer, 2006 PubMed Europe PMC Scholia
  18. Pagano M, Jackson PK; ''Wagging the dogma; tissue-specific cell cycle control in the mouse embryo.''; Cell, 2004 PubMed Europe PMC Scholia
  19. Gong H, Cao Y, Han G, Zhang Y, You Q, Wang Y, Pan Y; ''p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage''; DOI: 10.3892/ijo.2017.3922, 2017 PubMed Europe PMC Scholia
  20. Antoni L, Sodha N, Collins I, Garrett MD; ''CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?''; Nat Rev Cancer, 2007 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
128756view12:53, 21 February 2024EweitzUpgrade disease node, standardize case
128755view12:50, 21 February 2024EweitzStandardize case
128356view13:56, 2 February 2024EweitzImprove color readability, refine legend, standardize case
126216view15:01, 16 April 2023EgonwLicense is CCZero
124174view12:52, 23 September 2022VanessaSousaAKT1 gene is involved in DNA damage response
116541view12:11, 7 May 2021EweitzModified title
113795view10:06, 24 November 2020Finterlysmall graphical update
110587view20:47, 19 May 2020Khanspersupdated complexes, legend
107190view14:27, 17 September 2019MaintBotChEBI identifier normalization
106373view00:56, 23 August 2019KhanspersModified description
105499view05:53, 8 August 2019KhanspersModified description
105227view01:43, 23 July 2019Khansperssimplified legend, updated colors/layout, added cell shape etc
94731view14:50, 5 October 2017Ryanmillerconnected lines
82937view22:59, 13 November 2015AlexanderPicofixed character corruption
82193view16:31, 12 September 2015EgonwFixed weird characters in autors names.
82188view17:24, 11 September 2015EgonwMarked 'Alkylating agents' as a metabolite (to make the ChEBI link out work).
81804view14:56, 30 August 2015EgonwGave 'alkylating agents' a ChEBI identifier.
79975view12:15, 29 April 2015ZariCorrected I Ensembl
78527view10:29, 7 January 2015MaintBotadded missing graphIds
75226view18:29, 12 May 2014Khanspersimproved layout, fixed legend
70110view19:07, 12 July 2013MaintBotupdated to 2013 schema
69905view19:30, 11 July 2013AlexanderPicoModified title
67787view15:18, 26 June 2013DdiglesOntology Term : 'DNA damage response pathway' added !
67155view10:13, 26 June 2013Christine ChichesterOntology Term : 'stress response pathway' added !
59084view22:02, 21 February 2013MaintBotUpdated Ensembl data source
45196view10:06, 7 October 2011MartijnVanIerselOntology Term : 'p53 signaling pathway' added !
41047view23:16, 1 March 2011MaintBotRemoved redundant pathway information and comments
38647view12:30, 23 September 2010Mkutmonadding pathway links for "cell cycle", "apoptosis" and "senescence"
38431view07:48, 13 September 2010Stan.gajMDM2 - Literature added
38403view16:35, 9 September 2010Stan.gajAdded MDM2 regulation of TP53
34441view18:18, 10 December 2009MaintBotAutomatic update of empty xrefs
33418view14:52, 30 November 2009MaintBotRemoved group label
30259view04:49, 25 July 2009AlexanderPicoModified categories
30034view09:44, 29 June 2009I379077Specify description
29860view08:48, 8 June 2009I379077Caption
29694view07:29, 28 May 2009I379077Modified description
29693view07:28, 28 May 2009I379077Modified description
29682view08:30, 27 May 2009I379077Specify description
29674view09:09, 26 May 2009I379077Reverted to version '07:07, 25 May 2009' by I379077
29673view08:41, 26 May 2009I379077Specify description
29672view08:41, 26 May 2009I379077cell propertiez
29658view07:07, 25 May 2009I379077Specify description
29583view08:18, 19 May 2009I379077Specify description
29555view07:41, 15 May 2009I379077Specify description
29542view09:04, 14 May 2009I379077Specify description
29541view08:42, 14 May 2009I379077Specify description
29540view07:03, 14 May 2009I379077Specify description
29527view07:24, 12 May 2009I379077Specify description
29526view07:23, 12 May 2009I379077Specify description
29525view07:21, 12 May 2009I379077Caption

External references

DataNodes

View all...
NameTypeDatabase referenceComment
7-hydroxystaurosporineMetabolite65225 (Chemspider)
ABL1GeneProductENSG00000097007 (Ensembl Human)
APAF1GeneProductENSG00000120868 (Ensembl Human)
ATMGeneProductENSG00000149311 (Ensembl Human)
ATRGeneProductENSG00000175054 (Ensembl Human)
ATRIPGeneProduct84126 (Entrez Gene)
BAXGeneProductENSG00000087088 (Ensembl Human)
BBC3GeneProductENSG00000105327 (Ensembl Human)
BIDGeneProductENSG00000015475 (Ensembl Human)
BRCA1GeneProductENSG00000012048 (Ensembl Human)
CASP3GeneProductENSG00000164305 (Ensembl Human)
CASP8GeneProductENSG00000064012 (Ensembl Human)
CASP9GeneProductENSG00000132906 (Ensembl Human)
CCNB1GeneProductENSG00000134057 (Ensembl Human)
CCNB2GeneProductENSG00000157456 (Ensembl Human)
CCNB3GeneProductENSG00000147082 (Ensembl Human)
CCND1GeneProductENSG00000110092 (Ensembl Human)
CCND2GeneProductENSG00000118971 (Ensembl Human)
CCND3GeneProductENSG00000112576 (Ensembl Human)
CCNE1GeneProductENSG00000105173 (Ensembl Human)
CCNE2GeneProductENSG00000175305 (Ensembl Human)
CDC25AGeneProductENSG00000164045 (Ensembl Human)
CDC25CGeneProductENSG00000158402 (Ensembl Human)
CDC2GeneProductENSG00000170312 (Ensembl Human)
CDK2GeneProductENSG00000123374 (Ensembl Human)
CDK4GeneProductENSG00000135446 (Ensembl Human)
CDK5GeneProductENSG00000164885 (Ensembl Human)
CDK6GeneProductENSG00000105810 (Ensembl Human)
CDKN1AGeneProductENSG00000124762 (Ensembl Human)
CDKN1BGeneProductENSG00000111276 (Ensembl Human)
CHEK1GeneProductENSG00000149554 (Ensembl Human)
CHEK2GeneProductENSG00000183765 (Ensembl Human)
CREBGeneProduct1385 (Entrez Gene)
CYCSGeneProductENSG00000172115 (Ensembl Human)
CaffeineMetabolite2424 (Chemspider)
DDB2GeneProductENSG00000134574 (Ensembl Human)
E2F1GeneProductENSG00000101412 (Ensembl Human)
EstradiolMetabolite16469 (ChEBI)
FANCD2GeneProductENSG00000144554 (Ensembl Human)
FASGeneProductENSG00000026103 (Ensembl Human)
GADD45AGeneProductENSG00000116717 (Ensembl Human)
GADD45BGeneProductENSG00000099860 (Ensembl Human)
GADD45GGeneProductENSG00000130222 (Ensembl Human)
H2AFXGeneProductENSG00000188486 (Ensembl Human)
HUS1GeneProductENSG00000188996 (Ensembl Human)
MDM2GeneProductENSG00000135679 (Ensembl Human)
MRE11GeneProduct4361 (Entrez Gene)
NBNGeneProduct4683 (Entrez Gene)
PIDDGeneProduct55367 (Entrez Gene)
PMAIP1GeneProductENSG00000141682 (Ensembl Human)
PMLGeneProductENSG00000140464 (Ensembl Human)
PRKDCGeneProductENSG00000121031 (Ensembl Human)
RAD17GeneProductENSG00000152942 (Ensembl Human)
RAD1GeneProductENSG00000113456 (Ensembl Human)
RAD50GeneProductENSG00000113522 (Ensembl Human)
RAD51GeneProductENSG00000051180 (Ensembl Human)
RAD52GeneProductENSG00000002016 (Ensembl Human)
RAD9AGeneProductENSG00000172613 (Ensembl Human)
RB1GeneProductENSG00000139687 (Ensembl Human)
RFCGeneProduct5981 (Entrez Gene)
RPA2GeneProductENSG00000117748 (Ensembl Human)
RRM2BGeneProductENSG00000048392 (Ensembl Human)
SESN1GeneProductENSG00000080546 (Ensembl Human)
SFNGeneProductENSG00000175793 (Ensembl Human)
SMC1AGeneProductENSG00000072501 (Ensembl Human)
TLK1GeneProductENSG00000198586 (Ensembl Human)
TLK2GeneProductENSG00000146872 (Ensembl Human)
TNFRSF10BGeneProductENSG00000120889 (Ensembl Human)
TP53AIP1GeneProductENSG00000120471 (Ensembl Human)
TP53GeneProductENSG00000141510 (Ensembl Human)
c-MycGeneProduct4609 (Entrez Gene)

Annotated Interactions

No annotated interactions

Personal tools